# Signet Therapeutics (Shenzhen) Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/signet-therapeutics-shenzhen-co

- Industry: Biotechnology
- Headquarters: Shenzhen, China
- Total disclosed funding: $30M
- Latest round: Series A (Jan 14, 2026)
- Investors on record: 8

## About

Established in 2020 and based in Shenzhen, China, Signet Therapeutics (Shenzhen) Co., Ltd. is a healthcare technology company that provides cancer innovative prescription drugs. The company is mainly involved in the field of chemical pharmacy, targeted drugs, medical, and health. The founder and CEO Dr. Haisheng Zhang graduated from Harvard University and worked at the Dana-Farber cancer institute. It has new drug research and development center in Shenzhen and Boston. In January 2026, Signet Therapeutics (Shenzhen) Co., Ltd. raised CNY 80 million in series A funding from returning investors Tiantu Capital, BOCG, Green Pine Capital Partners, XtalPi Inc. and new investor Intelligent collaboration.
The company's main business is research and development of immune cell technology, biomedical technology, and cancer innovative prescription drugs. The company has a self-developed disease model platform that uses in the field of stomach cancer, bowel cancer, lung cancer, and breast cancer.
The company’s revenue is generated by providing targeted cancer drugs.
The series A funding will be primarily used to advance the global Phase II clinical trial of the company's first pipeline drug, SIGX1094, and to support the IND filing and Phase I clinical trial of its second pipeline drug, SIGX2649.

## Funding rounds

- Series A, Jan 14, 2026, $11M — Tiantu Capital, Green Pine Capital Partners, XtalPi Inc., BOCG
- Seed, Oct 26, 2021, $9.4M — 5Y Capital, Tiantu Capital, Sky 9 Capital, BOCG, Yael Capital
- Angel, Mar 5, 2021, $9.2M — Tiantu Capital, Leaguer Group, Sky 9 Capital, XtalPi Inc.

## Investors

- Tiantu Capital (https://capitalatlas.ai/funds/tiantu-capital) — Angel, Seed, Series A
- Leaguer Group (https://capitalatlas.ai/funds/leaguer-group) — Angel
- Sky 9 Capital (https://capitalatlas.ai/funds/sky-9-capital) — Angel, Seed
- XtalPi Inc. — Angel, Series A
- 5Y Capital (https://capitalatlas.ai/funds/5y-capital) — Seed
- BOCG (https://capitalatlas.ai/funds/bocg) — Seed, Series A
- Yael Capital (https://capitalatlas.ai/funds/yael-capital) — Seed
- Green Pine Capital Partners (https://capitalatlas.ai/funds/green-pine-capital-partners) — Series A